{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:44:04Z","timestamp":1783046644508,"version":"3.54.6"},"reference-count":31,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,16]],"date-time":"2025-08-16T00:00:00Z","timestamp":1755302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The incidence and prevalence of obesity and related cardio-metabolic diseases are on the rise, posing a critical health care challenge to systems across the globe. Bariatric surgery is a therapeutic cornerstone for morbidly obese patients, besides novel medical treatments, partly by ameliorating metabolic inflammation, a hallmark of metabolic diseases. Acyl-CoA Binding Protein (ACBP), also known as diazepam-binding inhibitor (DBI), is a regulator of autophagy and metabolism, and has recently been shown to increase in individuals undergoing voluntary fasting and in patients with cancer cachexia-induced malnutrition. By analyzing a prospectively collected study with matched serum and liver samples from patients undergoing laparoscopic adjustable gastric banding at baseline and six months after surgery, we here demonstrate that ACBP serum levels significantly increase following bariatric surgery. Hepatic ACBP expression at baseline predicted weight loss six months after the procedure. The predictive value of ACBP warrants further study, as it could identify patients who benefit most from metabolic surgery in the future.<\/jats:p>","DOI":"10.3390\/biom15081173","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:53:12Z","timestamp":1755503592000},"page":"1173","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hepatic Expression of ACBP Is a Prognostic Marker for Weight Loss After Bariatric Surgery"],"prefix":"10.3390","volume":"15","author":[{"given":"Moritz","family":"Meyer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1678-5962","authenticated-orcid":false,"given":"Paul","family":"Gruber","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3217-3278","authenticated-orcid":false,"given":"Christina","family":"Plattner","sequence":"additional","affiliation":[{"name":"Biocenter, Institute of Bioinformatics, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Enrich","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6095-068X","authenticated-orcid":false,"given":"Andreas","family":"Zollner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almina","family":"Jukic","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Effenberger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Grander","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-2579","authenticated-orcid":false,"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Grabherr","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, and Metabolism, Medical University of Innsbruck, 6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,16]]},"reference":[{"key":"ref_1","unstructured":"NCD Risk Factor Collaboration (NCD-RisC) (2024). Worldwide trends in underweight and obesity from 1990 to 2022: A pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet, 403, 1027\u20131050."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17034","DOI":"10.1038\/nrdp.2017.34","article-title":"Obesity","volume":"3","author":"Hu","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaci.2020.08.013","article-title":"Regulating metabolic inflammation by nutritional modulation","volume":"146","author":"Mitchelson","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41577-019-0198-4","article-title":"The intestinal microbiota fuelling metabolic inflammation","volume":"20","author":"Tilg","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","article-title":"What is the pipeline for future medications for obesity?","volume":"49","author":"Melson","year":"2024","journal-title":"Int. J. Obes."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrgastro.2013.119","article-title":"Mechanisms underlying weight loss after bariatric surgery","volume":"10","author":"Miras","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"155114","DOI":"10.1016\/j.cyto.2020.155114","article-title":"Gastric banding-associated weight loss diminishes hepatic Tsukushi expression","volume":"133","author":"Grander","year":"2020","journal-title":"Cytokine"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1537-8950","article-title":"Hepatic Meteorin-like and Kr\u00fcppel-like Factor 3 are Associated with Weight Loss and Liver Injury","volume":"130","author":"Grander","year":"2021","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jhep.2009.06.016","article-title":"Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression","volume":"51","author":"Moschen","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7108075","DOI":"10.1155\/2018\/7108075","article-title":"Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression","volume":"2018","author":"Adolph","year":"2018","journal-title":"J. Obes."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.15698\/cst2019.10.200","article-title":"Acyl-CoA-binding protein (ACBP): The elusive \u2018hunger factor\u2019 linking autophagy to food intake","volume":"3","author":"Pedro","year":"2019","journal-title":"Cell Stress"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41419-020-2716-5","article-title":"Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)\/diazepam binding inhibitor (DBI)","volume":"11","author":"Joseph","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neuron.2013.04.026","article-title":"Endogenous positive allosteric modulation of GABA(A) receptors by diazepam binding inhibitor","volume":"78","author":"Christian","year":"2013","journal-title":"Neuron"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.200911154","article-title":"Unconventional secretion of Acb1 is mediated by autophagosomes","volume":"188","author":"Duran","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.200909154","article-title":"A yeast MAPK cascade regulates pexophagy but not other autophagy pathways","volume":"189","author":"Manjithaya","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.cmet.2019.07.010","article-title":"Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity","volume":"30","author":"Sica","year":"2019","journal-title":"Cell Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41419-021-03864-9","article-title":"Effects of acyl-coenzyme A binding protein (ACBP)\/diazepam-binding inhibitor (DBI) on body mass index","volume":"12","author":"Joseph","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2207344119","DOI":"10.1073\/pnas.2207344119","article-title":"ACBP\/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis","volume":"119","author":"Lambertucci","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40618-018-0892-2","article-title":"Mechanisms underlying the weight loss effects of RYGB and SG: Similar, yet different","volume":"42","author":"Pucci","year":"2019","journal-title":"J. Endocrinol. Invest."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/gut.2010.214577","article-title":"Anti-inflammatory effects of excessive weight loss: Potent suppression of adipose interleukin 6 and tumour necrosis factor alpha expression","volume":"59","author":"Moschen","year":"2010","journal-title":"Gut"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1080\/15548627.2022.2160565","article-title":"DBI\/ACBP is a targetable autophagy checkpoint involved in aging and cardiovascular disease","volume":"19","author":"Joseph","year":"2023","journal-title":"Autophagy"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mohammad, S., and Thiemermann, C. (2020). Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.594150"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2018.06.014","article-title":"Experimental human endotoxemia as a model of systemic inflammation","volume":"159","author":"Geven","year":"2019","journal-title":"Biochimie"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.surg.2011.09.038","article-title":"Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus","volume":"151","author":"Monte","year":"2012","journal-title":"Surgery"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1007\/s11695-020-05011-3","article-title":"Preoperative Level of Leptin Can Be a Predictor of Glycemic Control for Patients with Diabetes Undergoing Bariatric Surgery","volume":"30","author":"Cabrera","year":"2020","journal-title":"Obes. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"O1","DOI":"10.1002\/oby.22719","article-title":"Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures\u20142019 Update: Cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists","volume":"28","author":"Mechanick","year":"2020","journal-title":"Obesity"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Seifert, G., Fagnocchi, L., Edozie, M., Herrmann, S., Baumann, H., Panzeri, I., Mewes, S., Aicher, D., Runkel, M., and L\u00e4ssle, C. (2023). The DECON pilot project investigates predictive markers for successful bariatric surgery. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-40452-7"},{"key":"ref_30","first-page":"434","article-title":"ACBP\/DBI neutralization for the experimental treatment of fatty liver disease","volume":"32","author":"Lambertucci","year":"2024","journal-title":"Cell Death Differ."},{"key":"ref_31","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), and European Association for the Study of Obesity (EASO) (2024). EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol., 81, 492\u2013542."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/8\/1173\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:28:50Z","timestamp":1760034530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/8\/1173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,16]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["biom15081173"],"URL":"https:\/\/doi.org\/10.3390\/biom15081173","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,16]]}}}